Original Publication Date: 1 November, 2014
Publication / Source: CNS Oncology
Authors: Seymur Gahramanov, Csanad Varallyay, Rose Marie Tyson et al
Aims: This retrospective study determined the survival of glioblastoma patients with or without pseudoprogression. Methods: A total of 68 patients were included. Overall survival was compared between patients showing pseudoprogression (in most cases diagnosed using perfusion MRI with ferumoxytol) and in patients without pseudoprogession. MGMT methylation status was also analyzed in the pseudoprogression cases.